MHRA completes inspection at Lupin’s three manufacturing units in Pithampur
27th Jan 2020

UK Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK) has successfully completed inspection at Lupin’s three manufacturing units in Pithampur in the state of Madhya Pradesh. The inspection for the three units at Pithampur closed with no critical observation and one major observation.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.